Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Susan Rodriguez Insider Profile
4 Followers
Susan Rodriguez, CCO at Ardelyx, holds 87.18K shares in Heron Therapeutics (Ticker: HRTX), holds 42.11K shares in Veradigm (Ticker: MDRX), holds 449.09K shares in Ardelyx (Ticker: ARDX).
Profitable Transactions
5 out of 12 Profitable Transactions
Average Return
-97.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Susan Rodriguez holds in companies
Most Profitable Insider Trade
The most profitable trade made by Susan Rodriguez
Susan Rodriguez's Trading History
Ardelyx
May 23, 2024
CCO
Uninformative Sell
52.35K
$2.27M
Heron Therapeutics
Feb 03, 2025
Director
Uninformative Buy
―
$150.82K
Veradigm
Jun 20, 2024
Director
Uninformative Buy
―
$214.74K
List of latest transactions for each holding click on a transaction to see Susan Rodriguez's performance on stock
You May Also Like
Susan Rodriguez insider profile FAQ
What is the percentage of profitable transactions made by Susan Rodriguez?
The percentage of profitable transactions made by Susan Rodriguez is 42%.
What is the average return per transaction made by Susan Rodriguez?
The average return per transaction made by Susan Rodriguez is -97.50%.
What stocks does Susan Rodriguez hold?
Susan Rodriguez holds: ARDX, HRTX, MDRX stocks.
What was Susan Rodriguez’s latest transaction?
Susan Rodriguez latest transaction was an Uninformative Buy of ―.
What was Susan Rodriguez's most profitable transaction?
Susan Rodriguez’s most profitable transaction was an Informative Sell of ARDX stock on May 21, 2021. The return on the trade was 90.60%.
What is Susan Rodriguez's role in Ardelyx?
Susan Rodriguez's role in Ardelyx is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.